SERVE - Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function
01.10.2017
This study assesses in a pilot trial the effect of PDE-5 inhibition with Tadalafil on RV size and function, exercise capacity and neurohumoral activation in adults with a systemic RV over a 3-year follow-up period.
Included patients: Adults (≥18 year...
Klinische Forschung -
01.10.2017 - 01.07.2021
Abgeschlossen
Projektleitung: Engel Reto
Mitarbeiter/innen: Gemperle Michaela
Weiter